Blood Glucose Monitoring Device Market, [By Products (Single Point Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitters), Glucose Monitoring strips, Lancet); By End Use (Hospitals & Clinics, Diagnostic Centers, Home care Settings); By Region Market size & Forecast, 2018 – 2026

  • Report Id: PM1564
  • Published Date: November, 2018
  • No of Pages: 110
  • Format: Electronic (PDF)
  • Publisher: Polaris Market Research
  • Category:

The Blood Glucose Monitoring Device market is anticipated to reach over USD 2.61 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the orthopedic treatment dominated the global Blood Glucose Monitoring Device market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue in 2017.

The increasing need for home care diagnosis and real time data by the end users to primarily drive the blood glucose monitoring device market during the forecast period. These devices have potential market due to the rising technology advancements in this industry during the forecast period. Moreover, the major supporting factor for this market growth is the number of populations suffering from diabetes. According to the World Health Organization (WHO), approximately there were direct deaths if 1.6 million in 2015, and this number is attributed to rise by 2030 making diabetes the 7th leading cause of death globally.

Furthermore, the changing life style of the people, and rising preference to the sedentary life style to also support the market growth in the coming years. However, lack of awareness, limited use of these devices, and no proper reimbursements regulation by the government would impede the market growth during the forecast period.

North America generated the highest revenue in the Blood Glucose Monitoring Device market in 2017, and is expected to be the leading region globally during the forecast period. Increasing demand, rising patient awareness for proper self-diagnosis methods, which saves the time, money, and provides accurate real-time data about the patient health. Also, decreasing cost & time of treatment, and continuous research and development in the same field to also boost the market growth in coming years. While, Asia Pacific blood glucose monitoring device market is supposed to the fastest growing market during forecast period.

The key players operating in the Blood Glucose Monitoring Device market include Abbott Laboratories, Terumo Corporation, ARKRAY Inc., Medtronic Plc., Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, Novo Nordisk A/S, Becton, Dickinson and Co., Sanofi, Bayer AG, Ypsomed AG. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Table of Contents

1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Blood Glucose Monitoring Device Market Insights
3.1. Blood Glucose Monitoring Device – Industry snapshot
3.2. Blood Glucose Monitoring Device – Ecosystem analysis
3.3. Blood Glucose Monitoring Device Market Dynamics
3.3.1. Blood Glucose Monitoring Device – Market Forces Blood Glucose Monitoring Device Market Driver Analysis Blood Glucose Monitoring Device Market Restraint/Challenges analysis Blood Glucose Monitoring Device Market Opportunity Analysis
3.4. Industry analysis – Porter’s five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Blood Glucose Monitoring Device Market PEST Analysis
3.6. Blood Glucose Monitoring Device Market Value Chain Analysis
3.7. Blood Glucose Monitoring Device Industry Trends
3.8. Competitive Ranking Analysis
4. Blood Glucose Monitoring Device Market Size and Forecast by Product Type, 2018-2026
4.1. Key Findings
4.2. Single Point Blood Glucose Meters (SBGM)
4.3. Continuous Glucose Monitoring Systems (CGM)
4.3.1. Sensors
4.3.2. Transmitters
4.4. Glucose Monitoring strips
4.5. Lancet
5. Blood Glucose Monitoring Device Market Size and Forecast by End Use Type, 2018-2026
5.1. Key Findings
5.2. Hospitals & Clinics
5.3. Diagnostic Centers
5.4. Home care Settings
6. Blood Glucose Monitoring Device Market Size and Forecast by Region, 2018-2026
6.1. Key Findings
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.3. Europe
6.3.1. Germany
6.3.2. UK
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Russia
6.3.7. Rest of Europe
6.4. Asia-Pacific
6.4.1. China
6.4.2. India
6.4.3. Japan
6.4.4. Singapore
6.4.5. Malaysia
6.4.6. Australia
6.4.7. Rest of Asia-Pacific
6.5. Latin America
6.5.1. Mexico
6.5.2. Brazil
6.5.3. Argentina
6.5.4. Rest of LATAM
6.6. Middle East & Africa
6.6.1. UAE
6.6.2. Saudi Arabia
6.6.3. South Africa
6.6.4. Rest of MEA
7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Overview
7.1.2. Financials
7.1.3. Product Benchmarking
7.1.4. Recent Developments
7.2. Terumo Corporation
7.2.1. Overview
7.2.2. Financials
7.2.3. Product Benchmarking
7.2.4. Recent Developments
7.3. ARKRAY Inc.
7.3.1. Overview
7.3.2. Financials
7.3.3. Product Benchmarking
7.3.4. Recent Developments
7.4. Medtronic Plc.
7.4.1. Overview
7.4.2. Financials
7.4.3. Product Benchmarking
7.4.4. Recent Developments
7.5. Acon Laboratories Inc.
7.5.1. Overview
7.5.2. Financials
7.5.3. Product Benchmarking
7.5.4. Recent Developments
7.6. Roche Diagnostics Ltd.
7.6.1. Overview
7.6.2. Financials
7.6.3. Product Benchmarking
7.6.4. Recent Developments
7.7. Johnson & Johnson Ltd.
7.7.1. Overview
7.7.2. Financials
7.7.3. Product Benchmarking
7.7.4. Recent Developments
7.8. Novo Nordisk A/S
7.8.1. Overview
7.8.2. Financials
7.8.3. Product Benchmarking
7.8.4. Recent Developments
7.9. Becton, Dickinson and Co.
7.9.1. Overview
7.9.2. Financials
7.9.3. Product Benchmarking
7.9.4. Recent Developments
7.10. Sonafi
7.10.1. Overview
7.10.2. Financials
7.10.3. Product Benchmarking
7.10.4. Recent Developments
7.11. Bayer AG
7.11.1. Overview
7.11.2. Financials
7.11.3. Product Benchmarking
7.11.4. Recent Developments

Choose License Type

Single user
Multi User
Enterprise User

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements


Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.